More Than $4M Bet On Better Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed lower by around 38 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Better Therapeutics

• The Trade: Better Therapeutics, Inc. BTTR 10% owner David P. Perry 2015 Trust acquired a total 4,969,697 shares an average price of $0.82. To acquire these shares, it cost around $4.1 million. The company’s other Directors also purchased the company’s shares.
• What’s Happening: Better Choice Company reported worse-than-expected Q4 sales results.
• What Better Therapeutics Does: Better Therapeutics Inc is a prescription digital therapeutics company developing a novel form of cognitive behavioural therapy to address the root causes of cardiometabolic diseases.

NN

• The Trade: NN, Inc. NNBR 10% owner Hjalmar Eric Soderlund acquired a total of 171,325 shares at an average price of $1.06. The insider spent around $182.11 thousand to buy those shares.
• What’s Happening: NN recently posted weaker-than-expected quarterly results.
• What NN Does: NN Inc is a diversified industrial company that combines engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision solutions and components.

Check This Out: Investor Optimism Improves Slightly Following Inflation Data

Heliogen

• The Trade: Heliogen, Inc. HLGN 10% owner Patrick Soonshiong acquired a total of 540,650 shares at an average price of $0.25. To acquire these shares, it cost around $135.04 thousand.
• What’s Happening: Heliogen recently posted a wider-than-expected quarterly loss.
• What Heliogen Does: Heliogen Inc is a concentrated solar energy system that is being developed to unlock the power of sunlight to replace fossil fuels.

Don’t forget to check out our premarket coverage here

Vicarious Surgical

• The Trade: Vicarious Surgical Inc. RBOT Director Philip Liang acquired a total of 17,002 shares at an average price of $2.26. The insider spent $38.41 thousand to buy those shares.
• What’s Happening: Vicarious Surgical, during February, posted a narrower-than-expected quarterly loss.
• What Vicarious Surgical Does: Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control.